ISPO

cancer vaccines

Enhancing the efficacy of Anticancer Vaccines: Learning who to immunize and when

RS Ellis MD, RS Chamberlain MD

Identification of HLA-A31-bound natural antigenic peptide of human gastric carcinoma cells and regulation of the antigen presentation by molecular chaperones

T Torigoe MD , H Sahara PhD , Y Nabeta MD , Y Hirohashi MD , K Kamiguchi MD , Y Okada MD , K Suzuki MD , T Yasoshima MD , S Takahashi MD , Y Wada MD , T Sato MD , K Hirata MD , K Kikuchi MD , N Sato MD

Cancer vaccines: Enhancing class I presentation of HER-2/neu-derived peptide antigens

BR Minev MD, JD Hipp BS

DNA vaccination prevents carcinoma development of papillomavirus-induced skin tumors on rabbits

ND Christensen PhD , R Han PhD , NM Cladel MSc , CA Reed BSc , LR Budgeon HTL , X Peng PhD

PX targets dendritic cells, induces their maturation and antigen delivery into the MHC class I presentation pathway leading to protective CTL tumor responses

P Jeannin PhD, L Goetsch PhD, JP Aubry PhD, Y Delneste PhD, T Renno PhD, JY Bonnefoy PhD

Induction of specific cytotoxic T cell activity against melanoma associated antigens with liposomal vaccines

M Adamina MD , C Noppen PhD , P Zajac PhD , E Padovan PhD , F Harder MD , M Heberer MD , GC Spagnoli MD

Immune responses against pathogenic self proteins by novel vaccines that provide cognate T cell help

AM Gautam PhD, L Steinaa, I Dalum PhD, MR Jensen PhD, S Mouritsen MD